Abbott Articles

US PHARMA INDEX LAUNCHED

29 June 1992

DYNAMICS OF THE US ANTIBIOTIC MARKET

22 June 1992

advance in renin research

15 June 1992

Stock Comment:SPECTRUM

15 June 1992

Stock Comment: New York

15 June 1992

ABBOTT WITHDRAWS TEMAFLOXACIN

15 June 1992

ABBOTT'S OMNIFLOX

8 June 1992

HORMONE REPLACEMENT THERAPY: US REPORT

8 June 1992

NO SALE OR MERGER OF SOLVAY PHARMA DIVISION

1 June 1992

US DRUG FIRMS' PUERTO RICO TAX CREDITS

25 May 1992

STOCK MARKET COMMENTARY: NEW YORK

11 May 1992

ABBOTT'S 2nd HEP C TEST APPROVED

11 May 1992

ARES SERONO - HOW TO PLAY THE STOCK

11 May 1992

STOCK MARKET COMMENTARY: NEW YORK

20 April 1992

IMPROVEMENTS IN 1ST QTR FOR US FIRMS

20 April 1992

NEW DIRECTOR AT ABBOTT LABS

20 April 1992

US FDA APPROVES ABBOTT BLOOD TEST

13 April 1992

US NEW PRESCRIPTI0N DRUG SALES IN 1991

13 April 1992

ABBOTT 1st QTR NET EARNINGS LEAP 16%

13 April 1992

ABBOTT TO SELL STAKE IN BOSTON SCIENTIFIC

13 April 1992

US PRESCRIPTION PRICES UP 8.1%IN 1991

23 March 1992

CHANGING FACE OF THE ASTHMA MARKET

9 March 1992

BELMAC CORP LOOKS TO USA

17 February 1992

BIO-MERIEUX NEEDS NEW FINANCE

17 February 1992

NEW CHEMICAL ENTITIES UPDATE FOR 1991

10 February 1992

MERCK'S PROSCAR NEARING US APPROVAL

10 February 1992

MS&D GREECE SALES RISE 19%

3 February 1992

ABBOTT SAYS SCHULER SUIT IS WITHOUT MERIT

27 January 1992

1991 A YEAR OF STRONG GROWTH IN THE USA

27 January 1992

FIRST LAUNCH OF LANSOPRAZOLE

20 January 1992

ABBOTT, AHP STRONG 4th QTR RESULTS

20 January 1992

US FDA BEATS 1990 DRUG APPROVALS IN 1991

13 January 1992

NEW DRUGS FOR EPILEPTICS

13 January 1992

FORTHCOMING MEETINGS

6 January 1992

Mylan launches generic Depakote ER in USA

Japan stock market week to Nov 14